|
Simoni-Wastila, L (P.I.),
"Impact of
3-Tier Copays on Use and Spending," Agency for Healthcare Research
and Quality with Brandeis University R01 H513092, $1,141,542 (2002
– 2005).
Description
Impact of 3-Tier
Copays on Use and Spending
Using data from a New England PPO,
this study examines the changes in drug and medical services
utilization and spending among individuals with depression or
asthma who were subjected to the implementation of a tiered
co-payment program.
Publication
None
at this time.
Presentation
Hodgkin D, Thomas CP,
Ritter G, Lee S, Leung M,
Simoni-Wastila L,
Hsu VD, Zhou Q, and Epstein D. Impact of a three-tier
formulary on utilization of antidepressant medications.
Annual meeting of the International Health Economics
Association July 10, 2005; Barcelona, Spain.
|
